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Significant obstructive jaundice in chronic pancreatitis is generally considered to be rare. Eleven of 57
consecutive patients with proven chronic pancreatitis have developed significant obstructive jaundice of
more than transient duration. Eight presented as jaundice complicating known pancreatitis and three as
jaundice of unknown cause.
Life table analysis showed a steady rise in the risk of developing jaundice up to the end of 10 years from
the onset of chronic pancreatitis. Jaundice was found to occur in the presence of more "destructive"
disease, and jaundiced patients had a higher incidence of pancreatic calcification, diabetes and
malabsorption at the time of presentation with jaundice.
Obstructive jaundice caused by chronic pancreatitis was found to carry a good prognosis for jaundice,
for pain and for life. Only one of the 11 patients died in hospital.
It is important to distinguish chronic pancreatitis from cancer in these patients. Pre-operative and intra-
operative cytology have been helpful. Stent insertion is not an appropriate method of treatment for these
patients because of the benign nature of the disease and the possibility of exacerbating the pancreatitis. It is
important to be aware of another form of "malignant masquerade" causing obstructive jaundice.
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INTRODUCTION
Approximately one third of patients with chronic pancreatitis develop jaundice1. It
may be due to hepatocellular disease or due to biliary obstruction. Abnormal liver
function tests and transient rises in bilirubin are reasonably common during acute
exacerbations of chronic pancreatitis2. In Bradley and Salam’s large series of 868
patients, 125 (14070) had jaundice. In 29 of the 125 jaundiced patients (22070), the
jaundice was due to extrahepatic obstruction. In only 13 patients (1.5070 of the total
series) was obstruction due to benign pancreatic disease. In the other 16 patients the
jaundice was secondary to gallstone disease3. In many patients stenosis of the
intrapancreatic portion of the common bile duct is clinically silent3’4’5. In others there
is an elevated alkaline phosphatase (S.A.P.) and this may be the earliest finding in
25678 patients with biliary obstruction In patients with incomplete biliary
obstruction biliary cirrhosis may supervene4’9. Lasting, clinically significant
obstructive jaundice is much less common being seen in less than 47o of cases in most
seriesl,3,0,11
Segal et al.9 have described three clinical types of chronic pancreatitis with biliary
obstruction transient, recurrent, and persistent. The present paper is concerned
solely with clinically significant and lasting jaundice, not with the transient variety.
Obstructive jaundice may present as a progressive problem. Sarle et al. emphasised
that anatomical changes in the common bile duct in patients with pancreatitis are
common but symptoms are rare. Obstructive jaundice may present as a progressive
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problem developing against the background of known pancreatitis. At other times, it
may present as relatively painless jaundice, making it difficult to distinguish from the
jaundice caused by cancer.
Just as there may be confusion with cancer, so there may be confusion between the
relative roles of chronic pancreatitis and biliary duct obstruction in causing pain.
Recently, routine biliary bypass has been advocated as part of a conservative surgical
program designed to preserve pancreatic function 12. The results of such methods of
treatment are not yet documented.
Finally, there is uncertainty about the factors which contribute to the development
of jaundice, and there is no clear patient profile which may alert a clinician to
anticipate incipient jaundice or to diagnose pancreatitis when the jaundice is
established.
MATERIALS AND METHODS
Patients presenting with proven chronic pancreatitis to one surgical unit between
1979 and 1986 have been included. All patients have been followed for at least two
years in order to exclude as far as possible those with undiagnosed malignancy. Only
patients with clinically significant and progressive obstructive jaundice caused by
pancreatic pathology and present for more than one week have been included.
Diagnosis of chronic pancreatitis was confirmed at autopsy in one patient. The
remainder were required to satisfy at least two of the following criteria: a typical
history of upper abdominal pain; documented rises in serum amylase; calcification in
the pancreas demonstrated on conventional radiology or computerised tomography;
an endoscopic retrograde cholangiopancreaticogram (ERCP) demonstrating ductal
irregularity and filling of the secondary ducts, dilatation of pancreatic ducts or
pancreatic calculi; and biopsy or cytological absence of malignancy. Patients with
jaundice caused by gallstones were excluded from the study. All patients have been
personally followed by one of the authors (JML).
Data has been gathered prospectively and maintained on a computerised database.
Statistics were calculated using a Stats plus programme. Non-parametric analysis was
used and Fisher’s exact test chosen to test the significance of results except where the
expected frequency was more than 5 in which case Chi-squared analysis was chosen.
RESULTS
General
Eleven patients of 57 with proven chronic pancreatitis presented with clinically
significant obstructive jaundice lasting more than one week. Seven of the 11 were
male, compared to 35 of the remaining 46 patients. The median age of the jaundiced
patients was 44 years (range 22-69 years). The median age of "the 46 non-jaundiced
patients was also 44 years (range 15 to 74 years). Three of the 11 patients presented as
jaundice of unknown cause. The remaining 8 were known to have chronic
pancreatitis before their jaundice developed. Specific details of liver function and of
common bile duct dilatation have been listed in Table 1.
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Table 1 Tests of Liver Function
Patient No. Bili SAP ALT GGT CBD diam. (mm)
90 275 154 138 14
2 92 360 232 800 15
3 136 198 150 161 17
4 430 1960 176 540 13
5 163 345 177 400 11
6 260 420 1010 1760 14
7 117 1610 75 480 15
8 *6 780 74 1410 13
9 146 253 239 229 +
10 464 264 138 464 13
11 68 316 98 202 14
Legend:
This patient presented with jaundice but treated by external drainage prior to referral hence the low bilirubin.
+ No measurement recorded of this patient’s dilated CBD.
years in the jaundiced patients (range 1-10 years). The median duration of symptoms
for the 46 non-jaundiced cases before presentation to this hospital for treatment was
5 years (range 1-50 years). A Mann-Whitney test shows this difference to be
statistically insignificant (z=-0.65, p>0.5). Life table analysis showed, however,
that the incidence of jaundice increased with time to 10 years from the date of first
symptoms (Figure 1). None of the 10 patients with symptoms for longer than 10 years
at the time of presentation to this hospital have become jaundiced. The increase in
risk appears to be linear, at a rate of about 2.6% of those at risk each year
(R2 .9309, p< .0001).
Aetiology ofpancreatitis
Five of the 11 jaundiced patients were alcoholics, four had idiopathic pancreatitis,
one post-traumatic pancreatitis and one familial pancreatitis. Twenty-eight of the 46
non jaundiced patients had alcoholic pancreatitis, 8 idiopathic pancreatitis, 3
pancreatitis following trauma, 2 familial pancreatitis and 5 chronic pancreatitis
secondary to biliary disease. There was no example of chronic biliary pancreatitis
amongst the jaundiced patients.
Pancreatic duct size
Pancreatic ducts were considered to be dilated if >7mm in size, a size determined as
being the minimum size suitable for pancreaticojejunostomy. Amongst the 11
jaundiced patients, 2 had small pancreatic ducts, 6 had irregular ducts dilated to less
than 7 mm., while 3 had ducts dilated to greater than 7 mm. diameter. Amongst the
remaining 46 patients, the ducts status was unknown in 10, small in 11, irregular and
slightly dilated in 8 and dilated beyond 7 mm. in 17. There did not appear to be any
preponderance of a particular pancreatic duct status amongst the jaundiced patients.
Glandular calcification
Radiological calcification was noted in 8 glands amongst the jaundiced patients,
while it was present in only 10 of the 46 non-jaundiced patients. This difference is
significant (chi-square 8.452, .005 > 2p> .001).266 M.J. HOLLANDS and J.M. LITTLE
Diabetes
Four of the 11 jaundiced patients had diabetes requiring insulin when they presented
with jaundice. This was true of only 4 of the 46 who were not jaundiced at first
presentation. Again this difference is significant (Fisher exact probability p-.037).
Malabsorption
Three of the 11 jaundiced patients had malabsorption at the time of presentation
with their jaundice that required permanent supplementation with pancreatic enzyme
preparations. Only 2 of the remaining 46 patients had malabsorption requiring
treatment. This difference is of marginal statistical significance (Fisher exact
probability p= .045).
Surgical Treatment
One patient required no surgical treatment, his jaundice subsiding spontaneously at
two weeks. In the remaining 10, the gallbladder was used as a bypass conduit 5 times,
and the common hepatic duct 4 times. One patient had a transduodenal
sphincterotomy.
The pancreatic pain was independantly treated in 5 patients, 3 times by
pancreaticojejunostomy, once by sphincteroplasty and once by total pancreatectomy.
Hospital Mortality
There was only one hospital death (within 30 days of surgery or before discharge
from hospital at any time). This death occured in a jaundiced patient, who developed
haemorrhigic pancreatitis as a complication of his chronic relapsing pancreatitis of
alcoholic origin.
Pain relief
At the time of writing, 9 of the 10 surviving patients from the jaundiced group were
pain free or reported significant improvement in their pain. This compares with 24 of
46 patients improved in the non-jaundiced group. This difference is statistically
significant (Fisher exact test p= .028).
DISCUSSION
It is important to recognise that the patients discussed in this paper had proven
chronic pancreatitis. Those with obstructive jaundice caused by stones have been
excluded, and indeed there was a notable absence of chronic biliary pancreatitis in
the jaundiced group. Each patient had clinically significant jaundice that persisted
for longer than a week, and all had evidence of duct obstruction with appropriate
liver function tests and dilated ducts demonstrated by ultrasound and/or
computerised tomography (CT) scanning.
When obstructive jaundice is defined in this fashion, the crude incidence in the 57
patients studied was 19%. This figure is higher than that reported in other
series1’3’’1. The cumulative frequency, as determined by life table analysis, reached
347o by the end of the 10th year from the onset of symptoms (Figure 1). Although
the numbers are far too small to generalise, the risk seems to diminish at about that
time, and none of the 10 patients with symptoms persisting for longer than 10 years






Obstructive jaundice was most commonly seen in those patients with known
chronic pancreatitis, and 8 of the 11 in this small study had known chronic
pancreatitis for a median of 7 years before jaundice developed. This represents 8
cases occuring in 54 patients with previously known pancreatitis, an incidence of 1570
at a median follow-up time of 5 years.
Less commonly, patients presented with obstructive jaundice of unknown cause,
and were found to have chronic pancreatitis. This represents a relatively rare
syndrome, which was noted only three times in 113 patients presenting with
obstructive jaundice as their primary problem during the same period.
There is some evidence from this study and others 12’14 that the disease is more
"destructive" in the patients who become jaundiced. There was a higher incidence of
diabetes, of glandular calcification and of clinically significant malabsorption
amongst the jaundiced patients. Calcification was also very common in the patients
described by other authors 1’5’15.
From a clinical point of view, distinction of chronic pancreatitis from cancer is all
important8’’15’6. The earliest surgical literature on this subject emphasises this
problem7’8’19’2. Even after extensive investigation, up to 10070 of patients may prove
to have unexpected cancers1’15. The diagnosis of cancer is particularly important in
an era when stenting is frequently employed as a method of palliative treatment for
malignant jaundice21’22. We have found preoperative and intraoperative cytology of
particular value in diagnosing carcinoma. The degree of confidence with which
cytology can rule out carcinoma is not yet known. While the specificity of cytological
examination for pancreatic cancer approaches 100070, the number of false negative
cases is yet to be ascertained accurately, but appears to be about 2007023,24,25 Such
negative or equivocal results continue to be a problem. We are at present following268 M.J. HOLLANDS and J.M. LITTLE
four patients with negative or equivocal cytology in whom we did not feel that radical
resection could be justified since no diagnosis of malignancy could be proven. None
of these patients complained of pain.
Only one of the 11 jaundiced patients in this series required no surgical treatment.
A number of operations can be used including sphincteroplasty,
choledochoduodenostomy, choledochojejunostomy, and cholecystojejunostomy.
Littenberg13 has emphasised that the technical factors are an important consideration
in the choice of operation. A small common bile duct represents one potential
hazard26. Sphincteroplasty should only be used if the stricture is short8. Some authors
have suggested that utilizing the gallbladder as a form of drainage conduit is
associated with an unsatisfactory incidence of cholangitis and the unpredictability of
the long term patency of the cystic duct11’13’27’28. Bradley and Salam3, have advocated
choledochoduodenostomy because bile is not diverted away from the duodenum,
because future pancreatic surgery is not compromised and because stricture from this
anastomosis is uncommon. In our experience it seems that the gallbladder works
perfectly well as a drainage conduit, as does the common hepatic duct. Pancreatitis
must be treated on its merits, and according to the size of the pancreatic duct.
Stenting is not favoured because of the common occurrence of cholangitis and
stent blockage21’22 as well as the theoretical risk of provoking acute pancreatitis from
partial pancreatic duct obstruction.
The outcome of treatment in these 11 patients has been remarkably good. Nine of
the 10 surviving patients have remained free of jaundice and with their pain
improved. One death occured in an alcoholic with an acute exacerbation of chronic
pancreatitis. He died as a result of multi-organ failure after a leak developed at the
site of his cholecystojejunal anastomosis. Warshaw et al. found similarly pleasing
results following surgical intervention and suggested that the patient’s pain in this
particular subset of patients was due to biliary as distinct from pancreatic
obstruction. Other authors3’5’29’3’3, however, found that pain was not improved
after biliary bypass. Since the minimum time of follow-up in this series of patients
has been two years, we would suggest that the improvement in pain is probably
clinically significant32. It is important that both physicians and surgeons dealing with
pancreatitis and dealing with obstructive jaundice remain aware of the association
between the two conditions. Jaundice due to biliary obstruction by benign pancreatic
pathology is easily overlooked but remains a remediable cause of symptoms and
complications in patients with chronic pancreatitis. It is also important to realise that
clinical jaundice due to chronic pancreatitis can present as relatively painless
jaundice, although it is more common to see jaundice in a patient with long-standing
chronic pancreatitis. Stenting should probably be avoided in such patients. The
general prognosis seems to be good for jaundice, for pain and for life. Chronic
pancreatitis may constitute yet another "malignant masquerade’’33 in jaundiced
patients.
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